Relaterat / Kontaktpersoner
Relaterat / Nyheter
Pressmeddelanden • Dec 09, 2010 14:24 CET
Vicore Pharma receives funding for development of angiotensin AT2-receptor agonists for potential treatment of multiple sclerosis
Pressmeddelanden • Dec 20, 2012 14:00 CET
Vicore Pharma today announced funding support from Fast Forward, LLC. The funding award will help support the research of angiotensin AT2-receptor agonists for the potential treatment of multiple sclerosis under a three-party collaboration with Vicore Pharma, The Department for Medicinal Chemistry at Uppsala University, Sweden and Charité Universitätsmedizin, Berlin, Germany.